Bladder

Home Bladder

Showing all 2 results

window.tgpQueue.add('tgpli-66230ab26f87c')<img width="600" height="600" src="https://medvitaz.com/wp-content/uploads/2020/12/padcev.jpg" class="attachment-thegem-product-catalog" alt="PADCEV (enfortumab vedotin-ejfv) for injection, for intravenous use. Initial U.S. Approval: 2019" />

PADCEV (enfortumab vedotin-ejfv) for injection, for intravenous use. Initial U.S. Approval: 2019

window.tgpQueue.add('tgpli-66230ab26f8a5')<img width="600" height="600" src="https://medvitaz.com/wp-content/uploads/2020/12/tecentriq.jpg" class="attachment-thegem-product-catalog" alt="TECENTRIQ ® (atezolizumab) injection" />

TECENTRIQ (atezolizumab) injection, for intravenous use. Initial U.S. Approval: 2016

Cancer that begins in the bladder. This cancer typically affects older adults. It’s usually diagnosed early, when it’s still treatable. It’s likely to recur, so follow-up tests are typically recommended. The most common symptom is blood in the urine. Treatments include surgery, biological therapy and chemotherapy.